Structural white matter properties and cognitive resilience to tau pathology
Alzheimer's & Dementia · 2024-05 · 20 (5) · 3364-3377
DOI: 10.1002/alz.13776 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024-04. Verfasst von Ting Qiu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Douglas Mental Health University Institute, Montreal, Canada. Hauptthemen laut MEDLINE: tau Proteins, White Matter. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chinese Scholarship Council, Canadian Institutes of Health Research foundation, Alzheimer's Society Canada and Brain Canada Research.
Abstract (Originalsprache)
INTRODUCTION We assessed whether macro‐ and/or micro‐structural white matter properties are associated with cognitive resilience to Alzheimer's disease pathology years prior to clinical onset. METHODS We examined whether global efficiency, an indicator of communication efficiency in brain networks, and diffusion measurements within the limbic network and default mode network moderate the association between amyloid‐β/tau pathology and cognitive decline. We also investigated whether demographic and health/risk factors are associated with white matter properties. RESULTS Higher global efficiency of the limbic network, as well as free‐water corrected diffusion measures within the tracts of both networks, attenuated the impact of tau pathology on memory decline. Education, age, sex, white matter hyperintensities, and vascular risk factors were associated with white matter properties of both networks. DISCUSSION White matter can influence cognitive resilience against tau pathology, and promoting education and vascular health may enhance optimal white matter properties. Highlights Aβ and tau were associated with longitudinal memory change over ∼7.5 years. White matter properties attenuated the impact of tau pathology on memory change. Health/risk factors were associated with white matter properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Douglas Mental Health University Institute, Montreal, Canada.
- Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.
- Medical Imaging and NeuroInformatics Lab, Université de Sherbrooke, Sherbrooke, Canada.
- Department of Radiology, Brigham and Women's Hospital, Mass General Brigham/Harvard Medical School, Boston, Massachusetts, USA.
- Sherbrooke Connectivity Imaging Laboratory, Université de Sherbrooke, Sherbrooke, Canada.
- School of Psychological Science, The University of Western Australia, Perth, Australia.
Förderung
- Chinese Scholarship Council
- Canadian Institutes of Health Research foundation
- Alzheimer's Society Canada and Brain Canada Research
Zitieren
APA
Qiu, T., Liu, Z. Q., Rheault, F., Legarreta, J. H., Valcourt Caron, A., St-Onge, F., Strikwerda-Brown, C., Metz, A., Dadar, M., Soucy, J. P., Pichet Binette, A., Spreng, R. N., Descoteaux, M., Villeneuve, S., & PREVENT‐AD Research Group (2024). Structural white matter properties and cognitive resilience to tau pathology. Alzheimer's & Dementia, 20(5), 3364-3377. https://doi.org/10.1002/alz.13776
Vancouver
Qiu T, Liu ZQ, Rheault F, Legarreta JH, Valcourt Caron A, St-Onge F, et al. Structural white matter properties and cognitive resilience to tau pathology. Alzheimer's & Dementia. 2024;20(5):3364-3377. doi:10.1002/alz.13776
BibTeX
@article{Qiu2024,
author = {Qiu, Ting and Liu, Zhen-Qi and Rheault, François and Legarreta, Jon Haitz and Valcourt Caron, Alex and St-Onge, Frédéric and Strikwerda-Brown, Cherie and Metz, Amelie and Dadar, Mahsa and Soucy, Jean-Paul and Pichet Binette, Alexa and Spreng, R Nathan and Descoteaux, Maxime and Villeneuve, Sylvia and PREVENT‐AD Research Group, PREVENT‐AD Research Group},
title = {Structural white matter properties and cognitive resilience to tau pathology},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {5},
pages = {3364--3377},
doi = {10.1002/alz.13776}
}
EUVIMED